Trial Profile
Certolizumab pegol in predicting role of synovial histopathology in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2016
Price :
$35
*
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 22 Aug 2016 New trial record